ARTICLE | Company News
Bristol-Myers Squibb other research news
December 6, 1993 8:00 AM UTC
Company scientists reported that the receptor coded for by the HER2 proto-oncogene appears to work together with another player to control breast cancers.
A newly characterized receptor called HER4 has to be associated with HER2 in order for HER2 to transduce the growth-regulating signal carried by heregulin, the researchers reported in Science. ...